Mesenchymal stromal/stem cells in drug therapy: New perspective

Area of Science:

• Cellular and Molecular Medicine
• Biotechnology
• Immunology

Background:

• Mesenchymal stromal cells (MSC) possess unique properties making them suitable for cellular delivery of therapeutic agents like nanoparticles, drugs, and micro-RNAs.
• Their applications span regenerative medicine, immune disorders, and anti-cancer therapies, highlighting their clinical significance.
• Ongoing research focuses on modifying MSC for enhanced targeted delivery and clinical efficacy.

Purpose of the Study:

• To review the effects of MSC in inflammatory microenvironments.
• To elucidate how MSC properties influence their application in cell therapy.
• To discuss the challenges and potential of MSC as drug delivery vehicles.

Main Methods:

• Literature review focusing on MSC properties and applications.
• Analysis of MSC interactions within inflammatory microenvironments.
• Discussion of MSC-based drug delivery systems and associated challenges.

Main Results:

• MSC exhibit properties beneficial for targeted therapies, including cancer treatment.
• The inflammatory microenvironment significantly influences MSC behavior and therapeutic potential.
• MSC can serve as effective vehicles for drug delivery, but their role in tumorigenesis necessitates careful consideration.

Conclusions:

• MSC hold significant promise for cell therapy and targeted drug delivery, especially in oncology.
• Understanding the microenvironmental impact on MSC is crucial for optimizing their therapeutic applications.
• Caution is advised regarding MSC use due to their potential involvement in tumorigenesis, demanding further research into safety and efficacy.